Validity and reliability study of the Turkish version of the tolerance for mental pain scale-10

IF 0.5 4区医学 Q4 PHARMACOLOGY & PHARMACY

Psychiatry and Clinical Psychopharmacology Pub Date : 2019-10-02 DOI:10.1080/24750573.2019.1699309

M. Demirkol, L. Tamam, Z. Namlı, Özge Eriş Davul

{"title":"Validity and reliability study of the Turkish version of the tolerance for mental pain scale-10","authors":"M. Demirkol, L. Tamam, Z. Namlı, Özge Eriş Davul","doi":"10.1080/24750573.2019.1699309","DOIUrl":null,"url":null,"abstract":"ABSTRACT OBJECTIVE: Psychological pain has been accepted as one of the most critical psychological risk factors underlying suicidal ideation and behaviour. Suicide is chosen as a way to get rid of intense, painful and unbearable psychological pain. Since the level of tolerance rather than the intensity of psychological pain was considered to be more predictive for suicide, we aimed to investigate the validity and reliability of the Turkish version of Tolerance for Mental Pain Scale-10 (TMPS-10). METHODS: A total of 121 patients diagnosed with depression in 62 of them had previous suicide attempts and 105 healthy controls who applied to the outpatient clinics of Çukurova University Faculty of Medicine Psychiatry Department were included in the study. Beck Depression Inventory (BDI), Beck Scale for Suicidal Ideation (BSIS), Beck Hopelessness Scale (BHS), Psychache Scale (PS) and TMPS-10 were applied to participants. RESULTS: In the internal consistency analysis, Cronbach’s alpha coefficient was 0.96 for enduring the pain, 0.96 for managing the pain, 0.98 for the whole scale, and item-total correlation coefficients were found to be between 0.87 and 0.93. The scale fit well to both the two-factor and single-factor structure in the confirmatory factor analysis. The multi-group confirmatory factor analysis showed that both the depressive patients and the control group interpreted the scale items in the same way. In convergent validity analysis, there was a negative, linear, high and statistically significant relationship between TMPS-10 scores and PS, BSIS, BDI and BHS scores (r = −0.935; −0.779; −0.890; −0.808; p < .0.001, respectively). In discriminant function analysis, TMPS-10 successfully differentiated the depressive group and the control group, as well as the depressive patients who did or did not attempt suicide (96.5%, 88.1%, respectively). CONCLUSION: The Turkish version of TMPS-10 is valid and reliable, and may be useful in research and clinical practices about suicide.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"28 1","pages":"899 - 906"},"PeriodicalIF":0.5000,"publicationDate":"2019-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry and Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/24750573.2019.1699309","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 6

Abstract

ABSTRACT OBJECTIVE: Psychological pain has been accepted as one of the most critical psychological risk factors underlying suicidal ideation and behaviour. Suicide is chosen as a way to get rid of intense, painful and unbearable psychological pain. Since the level of tolerance rather than the intensity of psychological pain was considered to be more predictive for suicide, we aimed to investigate the validity and reliability of the Turkish version of Tolerance for Mental Pain Scale-10 (TMPS-10). METHODS: A total of 121 patients diagnosed with depression in 62 of them had previous suicide attempts and 105 healthy controls who applied to the outpatient clinics of Çukurova University Faculty of Medicine Psychiatry Department were included in the study. Beck Depression Inventory (BDI), Beck Scale for Suicidal Ideation (BSIS), Beck Hopelessness Scale (BHS), Psychache Scale (PS) and TMPS-10 were applied to participants. RESULTS: In the internal consistency analysis, Cronbach’s alpha coefficient was 0.96 for enduring the pain, 0.96 for managing the pain, 0.98 for the whole scale, and item-total correlation coefficients were found to be between 0.87 and 0.93. The scale fit well to both the two-factor and single-factor structure in the confirmatory factor analysis. The multi-group confirmatory factor analysis showed that both the depressive patients and the control group interpreted the scale items in the same way. In convergent validity analysis, there was a negative, linear, high and statistically significant relationship between TMPS-10 scores and PS, BSIS, BDI and BHS scores (r = −0.935; −0.779; −0.890; −0.808; p < .0.001, respectively). In discriminant function analysis, TMPS-10 successfully differentiated the depressive group and the control group, as well as the depressive patients who did or did not attempt suicide (96.5%, 88.1%, respectively). CONCLUSION: The Turkish version of TMPS-10 is valid and reliable, and may be useful in research and clinical practices about suicide.

查看原文本刊更多论文

土耳其版心理疼痛耐受性量表-10的效度与信度研究

摘要目的:心理疼痛已被认为是自杀意念和行为背后最关键的心理危险因素之一。选择自杀是为了摆脱强烈的、痛苦的、难以忍受的心理痛苦。由于心理疼痛的耐受水平比心理疼痛的强度更能预测自杀，我们的目的是调查土耳其版心理疼痛耐受量表-10 (TMPS-10)的效度和信度。方法:121例抑郁症患者(其中62例有自杀倾向)和105例申请Çukurova大学医学院精神科门诊的健康对照者纳入研究。采用贝克抑郁量表(BDI)、贝克自杀意念量表(BSIS)、贝克绝望量表(BHS)、精神痛苦量表(PS)和TMPS-10量表对被试进行问卷调查。结果:在内部一致性分析中，忍受疼痛的Cronbach 's alpha系数为0.96，控制疼痛的Cronbach 's alpha系数为0.96，整个量表的Cronbach 's alpha系数为0.98，项目-总相关系数在0.87 ~ 0.93之间。在验证性因子分析中，量表对双因素结构和单因素结构均有较好的拟合。多组验证性因子分析结果显示，抑郁症患者与对照组对量表项目的理解方式相同。在收敛效度分析中，TMPS-10评分与PS、BSIS、BDI、BHS评分呈负向、线性、高度且有统计学意义(r =−0.935;−0.779;−0.890;−0.808;P < 0.001)。在判别函数分析中，TMPS-10成功区分了抑郁症组和对照组，以及有或没有自杀企图的抑郁症患者(分别为96.5%和88.1%)。结论:土耳其版TMPS-10量表有效可靠，可用于自杀研究和临床实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Psychiatry and Clinical Psychopharmacology Medicine-Psychiatry and Mental Health

CiteScore

1.00

自引率

14.30%

发文量

期刊介绍： Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.